181 related articles for article (PubMed ID: 12866287)
21. Relationship between bone mass, invasive breast cancer incidence and raloxifene therapy in postmenopausal women with low bone mass or osteoporosis.
Burshell AL; Song J; Dowsett SA; Mershon JL; Delmas PD; Secrest RJ; Cauley JA
Curr Med Res Opin; 2008 Mar; 24(3):807-13. PubMed ID: 18254988
[TBL] [Abstract][Full Text] [Related]
22. Raloxifene therapy in the reduction of fractures.
Cefalu CA
Am Fam Physician; 2000 Mar; 61(5):1272, 1275, 1279-80. PubMed ID: 10735336
[No Abstract] [Full Text] [Related]
23. Building bone.
Depree P
Adv Nurse Pract; 2000 Jan; 8(1):36-8. PubMed ID: 11011593
[No Abstract] [Full Text] [Related]
24. [MORE study(raloxifene)].
Itabashi A
Nihon Rinsho; 2004 Feb; 62 Suppl 2():442-9. PubMed ID: 15035168
[No Abstract] [Full Text] [Related]
25. [Relationship between changes in biochemical markers of bone turnover and prediction value of fracture risk].
Cyaki O
Clin Calcium; 2004 Oct; 14(10):39-46. PubMed ID: 15577130
[TBL] [Abstract][Full Text] [Related]
26. [From alcohol abstinence to total surgery. Preventive strategies in breast carcinoma].
Kreienberg R; Kafka A
MMW Fortschr Med; 2003 Jun; 145(24):32-3. PubMed ID: 12866296
[No Abstract] [Full Text] [Related]
27. Rationale for using raloxifene to prevent both osteoporosis and breast cancer in postmenopausal women.
Lee WL; Chao HT; Cheng MH; Wang PH
Maturitas; 2008 Jun; 60(2):92-107. PubMed ID: 18534794
[TBL] [Abstract][Full Text] [Related]
28. [Drugs in development for the treatment of osteoporosis:Raloxifene].
Taga M
Nihon Rinsho; 2002 Mar; 60 Suppl 3():572-80. PubMed ID: 11979956
[No Abstract] [Full Text] [Related]
29. Who will benefit from treatment with selective estrogen receptor modulators (SERMs)?
Sambrook P
Best Pract Res Clin Rheumatol; 2005 Dec; 19(6):975-81. PubMed ID: 16301191
[TBL] [Abstract][Full Text] [Related]
30. Comparison of fracture, cardiovascular event, and breast cancer rates at 3 years in postmenopausal women with osteoporosis.
Silverman SL; Delmas PD; Kulkarni PM; Stock JL; Wong M; Plouffe L
J Am Geriatr Soc; 2004 Sep; 52(9):1543-8. PubMed ID: 15341559
[TBL] [Abstract][Full Text] [Related]
31. Raloxifene. Not better than estrogen.
Can Fam Physician; 2000 Aug; 46():1592-6, 1599-603. PubMed ID: 10955178
[TBL] [Abstract][Full Text] [Related]
32. [Evidence-based assessment of therapeutic agents of osteoporosis. Bisphosphonates, SERM and basic therapy in front].
MMW Fortschr Med; 2003 Jul; 145(27-28):63. PubMed ID: 14587198
[No Abstract] [Full Text] [Related]
33. [Effects of SERMs on bone health. Efficacy of SERM for incidence of fractures in osteoporotic patients with lifestyle-related diseases].
Sakai A; Nakamura T
Clin Calcium; 2010 Mar; 20(3):322-9. PubMed ID: 20190361
[TBL] [Abstract][Full Text] [Related]
34. Raloxifene: bone and cardiovascular effects.
Francucci CM; Romagni P; Boscaro M
J Endocrinol Invest; 2005; 28(10 Suppl):85-9. PubMed ID: 16550730
[TBL] [Abstract][Full Text] [Related]
35. [Raloxifene: a selective modulator of estrogen receptors].
van den Brûle FA; Kalbus MF; Gaspard UJ
J Gynecol Obstet Biol Reprod (Paris); 1999 Dec; 28(8):788-99. PubMed ID: 10635481
[TBL] [Abstract][Full Text] [Related]
36. Bone turnover matters: the raloxifene treatment paradox of dramatic decreases in vertebral fractures without commensurate increases in bone density.
Riggs BL; Melton LJ
J Bone Miner Res; 2002 Jan; 17(1):11-4. PubMed ID: 11771656
[No Abstract] [Full Text] [Related]
37. Raloxifene and prevention of vertebral fracture (cont'd): mainly when oestrogen is contraindicated.
Prescrire Int; 2000 Dec; 9(50):190-1. PubMed ID: 11475503
[TBL] [Abstract][Full Text] [Related]
38. [SERM and quality of bone].
Sohen S
Clin Calcium; 2004 Oct; 14(10):96-9. PubMed ID: 15577138
[TBL] [Abstract][Full Text] [Related]
39. [Effects of SERM on breast cancer and cardiovascular disease: making a comparison between raloxifene use and hormone replacement therapy on the risks of the diseases].
Higuchi T; Mizunuma H
Clin Calcium; 2004 Oct; 14(10):81-4. PubMed ID: 15577136
[TBL] [Abstract][Full Text] [Related]
40. Medications for postmenopausal osteoporosis prevention.
Harv Womens Health Watch; 2002 Dec; 10(4):6-7. PubMed ID: 12499127
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]